Miguel Sanjuan
Founder & Strategic Scientific AdvisorDr. Miguel Sanjuan is Founder & Strategic Scientific Advisor of Bolt Biotherapeutics, Inc. He has been Senior Vice President of Research and Early Development at Provention Bio, Inc. since November 2021. Dr Sanjuan is Founder and Strategic Scientific Advisor at Prana Therapies, Inc. Dr. Sanjuan has years of research experience that spans both industry and academia. Dr. Sanjuan most recently served as vice president, head of translational biology at Gossamer Bio and founder of Gossamer's therapeutic biologics group. Prior to joining Gossamer Bio, Dr. Sanjuan was the head of immuno-oncology small molecule discovery biology at Bristol Myers Squibb. Prior to Bristol Myers Squibb, Dr. Sanjuan was an associate director at the Respiratory, Inflammation & Autoimmunity Department at Medimmune, focused on the discovery of novel molecules for the treatment of autoimmune disorders. Prior to joining industry, Dr. Sanjuan served as a research scientist at St. Jude Children's Research Hospital. Dr. Sanjuan received a bachelor's degree in biology from the University of Seville and a doctorate in molecular biology from the Autonomous University of Madrid and pursued post doctorate training at Johnson & Johnson in San Diego, California.
Positions
- Company NameBolt Biotherapeutics, Inc.Stock CodeBOLTPositionFounder & Strategic Scientific Advisor
